Anti-Human RON Recombinant Antibody (Narnatumab) (CAT#: TAB-184)

Recombinant monoclonal antibody to RON. Narnatumab is a human monoclonal antibody designed for the treatment of cancer.


Specific Inquiry
  • Size:
  • Conjugation:
  • Endotoxin:
  • Purity:
  • Fc Engineering:
  • Gene Expression
  • Datasheet
  • MSDS
  • COA
Subcellular Location
Normal Tissue
RNA Expression

Specifications

  • Immunogen
  • RE7 cells and MDCK cells overexpressing the human RON receptor in complete Freund`s adjuvant
  • Host Species
  • Human
  • Derivation
  • Human
  • Type
  • IgG1 - kappa
  • Specificity
  • Tested positive against native human antigen.
  • Species Reactivity
  • Human
  • Applications
  • Suitable for use in IF, IP, Neut, FuncS, ELISA, FC, ICC and most other immunological methods.
  • CAS
  • 1188275-92-4
  • Generic Name
  • Narnatumab
  • MW
  • 145.9 kDa
  • Related Disease
  • Solid tumors

Product Property

  • Purity
  • >95.0% as determined by analysis by SDS-PAGE.
  • Storage
  • Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.

Target

  • Alternative Names
  • Narnatumab;1188275-92-4;IMC-RON8;MST1R;macrophage stimulating 1 receptor (c-met-related tyrosine kinase);PTK8, PTK8 protein tyrosine kinase 8 , RON;macrophage-stimulating protein receptor;CD136;CDw136;p185-Ron;MSP receptor;RON variant E2E3;MST1R variant R

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "Narnatumab"

Afuco™ Anti-MST1R ADCC Recombinant Antibody (Narnatumab), ADCC Enhanced
This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant monoclonal antibody to RON. Narnatumab is a human monoclonal antibody designed for the treatment of cancer.

See other products for "MST1R"

Blocking Antibody

CAT Product Name Application Type
NEUT-1756CQ Recombinant Mouse Anti-MST1R Antibody (CBL312) BL IgG1

Neutralizing Antibody

CAT Product Name Application Type
NEUT-1757CQ Recombinant Mouse Anti-MST1R Antibody (MM0478-10F24) Neut IgG1

Rabbit Monoclonal Antibody

CAT Product Name Application Type
MOR-2309 Hi-Affi™ Recombinant Rabbit Anti-MST1R Monoclonal Antibody (DS2309AB) FC, ICC/IF, IHC-P, IP, WB IgG

ADCC Enhanced Antibody

CAT Product Name Application Type
AFC-TAB-184 Afuco™ Anti-MST1R ADCC Recombinant Antibody (Narnatumab), ADCC Enhanced FuncS, IF, Neut, ELISA, FC, IP ADCC enhanced antibody

Customer Reviews and Q&As

Submit a review or a question
There are currently no Customer reviews or questions for TAB-184. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.

For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

© 2024 Creative Biolabs.
  • 0
  • 0
Cart

    Go to compare